RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 98 filers reported holding RELMADA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,500 | +22.0% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $6,150 | +8.8% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $5,650 | -35.2% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $8,725 | -90.9% | 2,500 | -3.7% | 0.00% | -93.8% |
| Q3 2022 | $96,000 | +100.0% | 2,596 | +2.9% | 0.02% | +100.0% |
| Q2 2022 | $48,000 | -28.4% | 2,523 | +0.9% | 0.01% | -20.0% |
| Q1 2022 | $67,000 | +19.6% | 2,500 | 0.0% | 0.01% | +11.1% |
| Q4 2021 | $56,000 | – | 2,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,270,072 | $61,269,000 | 9.93% |
| GREAT POINT PARTNERS LLC | 790,000 | $21,322,000 | 5.15% |
| ACUTA CAPITAL PARTNERS, LLC | 342,000 | $9,231,000 | 4.31% |
| COWEN AND COMPANY, LLC | 1,164,361 | $31,426,000 | 3.02% |
| Altium Capital Management LP | 206,000 | $5,560,000 | 1.86% |
| BVF INC/IL | 1,647,400 | $44,463,000 | 1.78% |
| RTW INVESTMENTS, LP | 2,540,074 | $68,557,000 | 1.42% |
| Vivo Capital, LLC | 705,882 | $19,052,000 | 1.31% |
| RA Capital Management | 2,000,000 | $53,980,000 | 1.18% |
| SPHERA FUNDS MANAGEMENT LTD. | 291,252 | $7,861,000 | 1.11% |